Liver functions during pyrazinamide therapy

Kamal, N.; Mukerjee, P.K.; Kishore, K.; Kumar, S. and Khanna, B.K. (1976) Liver functions during pyrazinamide therapy. Indian Journal of Tuberculosis, 23 (1). pp. 14-18.

Full text available as:

PDF - Requires Adobe Acrobat Reader or other PDF viewer.
146 Kb


69 proved cases of pulmonary tuberculosis were studied for 6 months. They were getting pyrazinamide 30 mg/kg of body weight in the daily and biweekly regimen groups, respectively. On initiation of the therapy and after every one month serum pyrazinamide concentrations, SGPT, SGOT and serum alkaline phosphatase of all the patients of both groups were estimated. It was concluded that rise in the levels of SGPT, SGOT and serum alkaline phosphatase, during therapeutic administration of pyrazina- mide did not imply impending hepatic damage (during an observation period of 6 months). The rise in the level of these enzymes paralleled the rise in the level of serum pyrazinamide.

EPrint Type:Article
Uncontrolled Keywords:Pyrazinamide, Drug Therapy, Pulmonary Tuberculosis, Liver Functions, Hepato-toxicity, SGOT, SGPT
Subjects:Disorders of Environmental Origin > Poisoning > Drug Toxicity
Diagnosis > Diagnostic Techniques and Procedures
Enzymes and Coenzymes > Enzymes > Hydrolases
Enzymes and Coenzymes > Enzymes > Transferases
Respiratory Tract Diseases > Respiratory Tract Infections > Tuberculosis, Pulmonary
Digestive System > Liver
Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyrazines
Respiratory Tract Diseases > Lung Diseases > Tuberculosis, Pulmonary
-Journal Repositories > Indian Journal of Tuberculosis
Digestive System Diseases > Liver Diseases
ID Code:1577
Deposited By:Mrs Naina Pandita
Deposited On:16 November 2006

Archive Staff Only: edit this record